chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Screaming continuously for >3 hrs. Had fever but to 102 / Ax was highest.
12/14/21 Dryness and discharge in and around ears. Went to Hospital ER. They say its sebaceous dermatitis and was told to wash area with anti dandruff shampoo. 1/19/22 Condition continues. Visit to Dr, primary condition confirms previous diagnosis and was advised to use Aquaphor lotion. 3/3/22 Conditions continue and worsen,with itching developing. Visit to Dr, dermatologist diagnoses me with exzema. I have never had this condition before. I was prescribed Hydrocortisone 2.5% cream, ketoconazole cream and vanicream z  soap. As of today, my condition has improved but not gone away. I am currently using aveeno exzema cream.
Patients received the Moderna Covid 19 vaccine after temperature excursion; Patients received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 14-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that there had been temperature excursions with the freezer that was happened for weeks since April 2022.Storage condition at the time of the excursion were frozen. It was reported that Lot numbers: 065K21A and Lot numbers 045L21A had undergone temperature excursion and maximum and minimum temperatures reached were 30 Fahrenheit Degrees and minus 18.9 Fahrenheit Degrees respectively. It was reported that the vaccines suffered 2 temperature excursions since April, both lasted less than 1 minute and date the vials moved from freezer to refrigerator was unknown, they were now stored in frozen condition and No vaccine state change was observed. No treatment medications were reported.   This case was linked to MOD-2022-591989 (Patient Link).
48 hours after Moderna vaccine [ given at outside facility] patient started with puffy eyes, rash around the eyes with redness of both eyes. Slowly the rash spread to entire face including the neck region. At 72 hours post vaccination she noted swelling and redness around the lips with tightness in chest prompting here to seek help. Noted to have generalized swelling and erythema to face along with the periorbital area and eye lids on exam [ after Benadryl]- no respiratory distress.  Reaction thought to possibly be an acute worsening of her underlying eczema but could not rule out vaccine reaction.  Treated with Benadryl, Zyrtec and Prednisone
Syncope- LOC last a couple seconds, patient fell to the ground.  VS were taken.  Physical examination including neurological assessment was completed.  Patient was  monitored  for over 20 minutes. He remained asymptomatic after initial episode.
Myalgia, Arthralgia & Fever Narrative: dose 1: pain/swelling at inj site day1-2; redness only day 3-7; fatigue day 1-2 dose 2: pain/swelling at inj sit site day 1-2; swelling day 3-4; day 2-body ache/fever/fatigue/ joint pain
After first dose which was on a Friday 01/15/2021  I started to get a rash on my neck, then over the weekend I got hives on my body. Then I called my Dr and he administered a steroid injection. Then it got better. After the second dose I received it on 02/ 12/21 and then on 02/26/2021 I did not fell well at all at work I told my SV I felt my right side of my face going numb, but I continued to work. Then later that night I notice my face I could not move it, and as I have a lot of medical knowledge I knew it was not a stroke, but Bell's palsy. I emailed my provider and he confirmed it was Bell's palsy and started me on a steroid medication. I am still on the medication and my face is still numb and droopy and I can not eat nor drink like normal, so while at work I try not to eat as it is very difficult and I shock and do not want my other co-workers seeing me this way.
pt recvd vax 5OCT93 & exp local skin react, area where immun red, felt warm to touch, swollen & felt knotty; taken to MD;
unspecified number of not previously vaccinated patients received first dose of PROQUAD at 12 months old; unspecified number of not previously vaccinated patients received first dose of PROQUAD at 12 months old; This spontaneous report was received from a physician, via a field employee, referring to an unspecified number of 12 month old patients. The patients' pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.      On unknown dates, not previously vaccinated patients received the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) by subcutaneous route, for prophylaxis which was diluted with sterile diluent (MERCK STERILE DILUENT) (therapy naive). No adverse effects were reported.  At the reporting time, the outcome of therapy naive was unknown. The causality assessment was not provided.
Left are was warm to the touch and slight sore, started throwing up around 5:45 pm and temperature was 102.3.  Threw up again in the night and started having diarrhea.  Still running 99.8 fever on 3/11/21
Choking; arm was really sore; Feels sleepy all the time; retching/gagging; Feels tired/fatigue; Anxiety; Cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHOKING (Choking) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pulmonary arterial hypertension since 12-Feb-2021 and Anxiety since 04-Mar-2021. Concomitant products included TREPROSTINIL SODIUM for Primary pulmonary hypertension.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. In February 2021, the patient experienced COUGH (Cough). On 04-Mar-2021, the patient experienced ANXIETY (Anxiety). On an unknown date, the patient experienced CHOKING (Choking) (seriousness criterion medically significant), PAIN IN EXTREMITY (arm was really sore), SOMNOLENCE (Feels sleepy all the time), RETCHING (retching/gagging) and FATIGUE (Feels tired/fatigue). At the time of the report, CHOKING (Choking), PAIN IN EXTREMITY (arm was really sore), SOMNOLENCE (Feels sleepy all the time), ANXIETY (Anxiety) and FATIGUE (Feels tired/fatigue) outcome was unknown and COUGH (Cough) and RETCHING (retching/gagging) was resolving.; Sender's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities.
Pfizer vaccine had been out of the freezer for more than 4 days.  Patient was informed of this and offered another vaccine.
Dizzy, clammy. No dyspnea. Ringing in ears, abdominal pain, nausea. No skin erruptions. Not responding appropriately to commands. Next day pt was achy and had abdominal pain.
A repot was received from a health care professional on 6OCT2003 concerning a female vaccine in her late thirties who experienced local sensitivity at the injection site on the same day as receiving Fluvirin vaccine on 3OCT2003 and shoulder joint pain which made it difficult to raise her arm an unspecified number of days after vaccination. On 3OCT2003 the vaccinee experienced local sensitivity at the injection site. An unspecified number of days later the vaccinee developed a shoulder joint pain that made it difficult for her to raise her arm. The vaccinee was to seek treatment from her physician. There was insufficient information to determine the reporter's causality assessment. Update 1 23DEC2003: A follow up report received from a health care professional which indicated that the 48 year old female vaccinee experienced shoulder joint ache on 4OCT2003. The shoulder joint ache resolved on 6OCT2003. no action was taken to treat this reaction. It was not reported if local sensitivity at the site of injection had resolved. Follow up pending.
Patient presented to the ED and was subsequently hospitalized on 4/10/21. She was also admitted to the hospital on 4/22/21.
Patient given vaccine during appointment around 0930. Around 0935 patient reported feeling of throat swelling and was coughing/clearing throat. Medical response was called. Patient was assessed, vitals taken and given 1 dose of Epinephrine - 0.3 mg IM. Epi was given at 0943. EMS was called and arrived around 0954. Patient transferred to ER for further evaluation. In ER was treated with Methylprednisolone, diphenhydramine and famotidine, at 1050. Discharged from ER.
Patient presented to emergency department due to a critical lab value indicating thrombocytopenia from his oncologist office. During admission patient was found to be COVID-19 positive. He became symptomatic and was treated with supplemental oxygen and dexamethasone. Patient was discharged home on 10/26/2021 with supplemental oxygen.
Pt recvd 1st dose of Engerix-B on 25OCT91 & on 25OCT91 PM pt exp fever & a hot sensation; tx none; pt was fine 48hrs later;
Pt was given an extra dosage of influenza, he was to be administered the HPV but was given flu and had already received Influenza on 10/28/2022. MOC was called and informed of this mistake.
PATIENT WAS ACCIDENTALLY INJECTED  WITH 0.3 ML OF  AIR INTRAMUSCULARY  IN THE  DELTOID MUSCLE  OF  HER LEFT ARM  .  PATIENT DID NOT EXPERIENCE AND  HAS NOT  REPORT ANY ADVERSE EFFECTS  FROM THIS  INCIDENT AS OF 06/14/21.
nausea approx 2hrs p/vax;pain @ inj site,shoulder was stiff;next day fatigue,h/a,joints achy,loss appetite;pain @ inj site & stiffness lasted 2-3days;rest of sx cont to persist
Information has been received from a physician concerning a 74 year old male with diabetes, cardiac disorder, hypertension, peripheral vascular disorder and Alzheimer's disease who in approximately October 2006, was vaccinated with a 0.65 ml dose of zoster vaccine live (Oka/Merck). In approximately September 2007, the patient developed a shingles outbreak. The patient's shingles outbreak persisted. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Woke up with sore left arm and some redness and swelling at injection site on 1.5.21.  Chills and generalized body aches began about 1230, temperature taken at that time was 99.0.  Continued with work and by 1530 began to have increased myalgias and pain in knees, took temperature 100.0 and took 400mg Ibuprofen.  Fever broke, began to have diaphoresis and felt body aches were gone with exception to left arm.  Woke up 1.6.21 and with pain in left axilla and noted to have tender and swollen lymphnodes.  Took another 400mg Ibuprofen about 0830.  Muscle pains remain to arm, axilla and neck.
Patient received a FLUZONE HD shot on 10-3-16 and on 10-4-16 presented at the pharmacy with a 2 inch red welt on her arm. Advised patient to take an antihistamine, ice the area and contact doctor if it progressed.
Information has been received from a physician concerning an 18 week (reported as 4.5 months) old male who was vaccinated with ROTATEQ vaccine live (human-bovine). The physician reported that the patient experienced diarrhea a couple of days after receiving the second dose of ROTATEQ vaccine live (human-bovine) and it lasted for 6 to 7 weeks. Subsequently, the patient recovered. There was no product quality complaint. Additional information is not expected.
covid; covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12May2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 17Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "idiopathic hypersomnia" (unspecified if ongoing); "inappropriate sinus tachycardia" (unspecified if ongoing); "Allergy-induced asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. No known allergy. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: tested positive 7 days after finishing paxlovid; Heart rate: inappropriate sinus tachycardia. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received 1st COVID vaccine.  She was then instructed to go to the counter to schedule her 2nd dose.  While at the counter, (1-2 minutes post dose) she started stumbling.  Our technician and pharmacist caught patient and lowered her to the ground as she was fainting (nothing hit the ground uncontrolled).  Patient never lost full consciousness.  Cold compress was applied to the back of her neck. Once she started feeling better (3 minutes), she sat up and drank some water.  After 2 more minutes, she moved to a chair.  She waited 15 additional minutes before leaving the pharmacy area. She reported she was feeling completely fine.
Covid vaccine interacted with Klonopin; This spontaneous case was reported by an other health care professional and describes the occurrence of DRUG INTERACTION (Covid vaccine interacted with Klonopin) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product CLONAZEPAM (KLONOPIN) for an unknown indication.    It was unknown that the patient had allergies to medication, food and other products. It was unknown that the patient had ever been diagnosed or tested positive for COVID-19. Chronic and acute illness at the time of vaccination and one month prior was unknown.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and CLONAZEPAM (KLONOPIN) (Oral) .5 milligram. On an unknown date, the patient experienced DRUG INTERACTION (Covid vaccine interacted with Klonopin). At the time of the report, DRUG INTERACTION (Covid vaccine interacted with Klonopin) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that, there was an interaction between clonazepam and COVID-19 vaccine. They were doing some investigation work and read that the COVID vaccine interacted with Klonopin and it was similar to the RabAvert. If the COVID vaccine taken with clonazepam, they heard the T Cell did not proliferate the right way.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Dec-2022: Followup received. Case updated as valid as specific patient identifier reported. Reporter details, co-suspect details and narrative updated.
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No Treatment information was reported.
Arrived to ED on 10/21/23 from assisted living after she was found down. Complained on left hip pain. CTA of the abdomen pelvis was performed which demonstrated an occlusion of the left external iliac artery as well as multiple occlusions noted throughout her bilateral lower extremities. Started on heparin gtt on 10/22/23. Patient expired 10/26/23.
Received 1st dose when approximately 6.5 weeks pregnant. Had a miscarriage 11 days post vaccine. Estimated due date was 4/22/2022
Patient was supposed to receive the Menigitis conjugate vaccine but received the meningitis B vaccine
Received Expired Dose of Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Patient receive her 1dose of covid vaccine at 0900. At around 0915 pt stated she feels nauseated and was having a hard time breathing with her mask on in a confined space. RN took her out to the hallway with door opened for ventilation. Patient felt better right away. Patient stated she felt better and want to go home. RN stayed with patient till 1000 and walk patient to her car.
pt recvd vax 455PM 11OCT95 & 503PM pt's mom told nurse pt was flushed;nurse noticed pt developing a rash on body;pt was asked by nurse if any diff breathing;pt states just itching;MD called & pt given DPH;pt devel breating diff;allerg rxn
weakness; sob; Rapid heartbeat; chest pain; dizziness; This is a spontaneous report from a contactable Nurse (patient). A 43-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection,Batch/Lot number: not reported), via an unspecified route of administration, administered in Arm Right on 15Apr2021 12:00 as DOSE 2, SINGLE for COVID-19 immunisation. Facility type for vaccination was Public Health Clinic. Medical history included covid-19 and If Covid prior vaccination: Yes.The patient did not receive any other vaccine in four weeks prior to the COVID vaccine. Unknown allergies was reported. Concomitant medication(s) included pregabalin (LYRICA), ibuprofen (IBUPROFEN), sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported) administered in Arm Left on 25Mar2021 12:00 as DOSE 1, SINGLE for COVID-19 immunisation. On 15Apr2021 12:00, the patient experienced sob, rapid heartbeat, chest pain, dizziness, weakness. Patient was not received any treatment.The patient underwent lab tests and procedures which included heart rate: rapid on 15Apr2021, sars-cov-2 test: negative on 01Apr2021.The outcome of events were not recovered.   Information about lot/batch number has been requested.
He was so sick everytime he took it for about a week and half, couldn't even get out if bed; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves male patient was so sick every time for about a week and half, couldn't even get out if bed (illness), while he received vaccine INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (Produced by unknown manufacturer, lot number and expiration date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was so sick every time for about a week and half couldn't even get out if bed (illness), unknown latency following the administration of INFLUENZA VACCINE.  Laboratory data was not reported.   It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown at the time of reporting.  There will be no information on the batch number for this case.
Left sided flank pain off and on beginning in late February.  Slow onset fatigue and decreased tolerance for larger meals noted. April 14, pain became consistent and bothersome.  April 15, left sided flank pain became debilitating, so sought medical care Urgent Care.  The physician performed a physical exam which showed marked tenderness in the left pelvic area and left flank.  The physician performed a POC ultrasound, transvaginal ultrasound, full lab workup, and ultimately referred for an CT Abdomen with contrast, which showed acute diverticulitis of the descending colon.
Information has been received from a registered nurse concerning a female student in her twenties who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not specified). The nurse stated that the patient had received one dose of GARDASIL and now her physician's office had been told her she had papilloma viral infection. The patient sought medical attentions at the physician's office. At the time of reporting, her outcome was unknown. Additional information has been requested.
Immediate pain in shoulder and radiating down arm. Large lump at injection site. Shoulder frozen within two days of injection on side of body injection occurred. Shoulder is still frozen six months later. Muscles hardened and stiff and pain is 24/7.